NCF4 (Neutrophil Cytosolic Factor 4)

title: NCF4 Gene

NCF4 (Neutrophil Cytosolic Factor 4)

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | NCF4 |
| Full Name | Neutrophil Cytosolic Factor 4 (p40^phox^) |
| Chr Location | 22q13.1 |
| NCBI Gene ID | 3074 |
| OMIM ID | 604467 |
| Ensembl ID | ENSG00000100129 |
| UniProt ID | Q9UHI5 |
| Encoded Protein | p40^phox^ |
| Associated Diseases | Chronic Granulomatous Disease, Parkinson's Disease, Alzheimer's Disease, Inflammatory Diseases |

</div>

Overview

NCF4 (Neutrophil Cytosolic Factor 4), also known as p40^phox^, is a regulatory subunit of the NADPH oxidase (NOX2) complex that plays a critical role in generating reactive oxygen species (ROS) in phagocytic cells. While primarily studied in neutrophils and other immune cells, NCF4 is also expressed in microglia—the resident immune cells of the brain—where it contributes to neuroinflammatory processes that are central to neurodegenerative disease pathogenesis [1][2].

The NADPH oxidase complex is a multi-subunit enzyme that generates superoxide anion (O₂⁻) through the one-electron reduction of molecular oxygen.[@c2022] The p40^phox^ subunit serves as a critical positive regulator of this complex, enhancing oxidase activity in response to inflammatory stimuli. Genetic variants in NCF4 have been associated with altered risk for Parkinson's disease (PD), making it a gene of interest in neurodegenerative disease research [1].[@j2024]

Molecular Structure and Biochemistry

Protein Architecture

title: NCF4 Gene

NCF4 (Neutrophil Cytosolic Factor 4)

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | NCF4 |
| Full Name | Neutrophil Cytosolic Factor 4 (p40^phox^) |
| Chr Location | 22q13.1 |
| NCBI Gene ID | 3074 |
| OMIM ID | 604467 |
| Ensembl ID | ENSG00000100129 |
| UniProt ID | Q9UHI5 |
| Encoded Protein | p40^phox^ |
| Associated Diseases | Chronic Granulomatous Disease, Parkinson's Disease, Alzheimer's Disease, Inflammatory Diseases |

</div>

Overview

NCF4 (Neutrophil Cytosolic Factor 4), also known as p40^phox^, is a regulatory subunit of the NADPH oxidase (NOX2) complex that plays a critical role in generating reactive oxygen species (ROS) in phagocytic cells. While primarily studied in neutrophils and other immune cells, NCF4 is also expressed in microglia—the resident immune cells of the brain—where it contributes to neuroinflammatory processes that are central to neurodegenerative disease pathogenesis [1][2].

The NADPH oxidase complex is a multi-subunit enzyme that generates superoxide anion (O₂⁻) through the one-electron reduction of molecular oxygen.[@c2022] The p40^phox^ subunit serves as a critical positive regulator of this complex, enhancing oxidase activity in response to inflammatory stimuli. Genetic variants in NCF4 have been associated with altered risk for Parkinson's disease (PD), making it a gene of interest in neurodegenerative disease research [1].[@j2024]

Molecular Structure and Biochemistry

Protein Architecture

The p40^phox^ protein is composed of several distinct domains that mediate its function:

• PX Domain (1-80 aa): Phosphoinositide-binding module that targets p40^phox^ to cellular membranes and phagocytic vesicles
• SH3 Domain (120-180 aa): Proline-rich region that mediates protein-protein interactions with other phox components
• PCD Domain (200-280 aa): Protein interaction domain
• C-terminal Region (280-339 aa): Regulatory domain controlling oxidase activity

The NADPH Oxidase Complex

The functional NADPH oxidase complex consists of five core components:

| Component | Gene | Function |
|-----------|------|----------|
| gp91^phox^ | CYBB | Catalytic subunit, forms the flavocytochrome b558 |
| p22^phox^ | CYBA | Stabilizes gp91^phox^, required for complex assembly |
| p47^phox^ | NCF1 | Cytosolic adaptor, organizes complex assembly |
| p67^phox^ | NCF2 | Cytosolic activator, contains activation domains |
| p40^phox^ | NCF4 | Positive regulator, enhances oxidase activity |

Regulatory Mechanisms

p40^phox^ enhances NADPH oxidase activity through several mechanisms:

• Stabilization of the p67^phox^-p47^phox^ complex in the cytosol
• Promotion of phagosomal localization
• Interaction with the Rac GTPase
• Phosphorylation-dependent activation

Physiological Functions

Immune System Function

In neutrophils, monocytes, and macrophages, p40^phox^ participates in the oxidative burst response:

• Host Defense: Generates ROS that kill engulfed pathogens
• Phagocytosis: Links NADPH oxidase activity to phagosome maturation
• Signal Transduction: ROS serve as second messengers in inflammatory signaling

Microglial NOX Biology in the CNS

CNS Immune Surveillance

Microglia, the resident immune cells of the brain, serve as the first line of defense in the central nervous system [11]. The NADPH oxidase complex, including p40^phox^, is a critical component of microglial immune function:

Baseline ROS Production: Even in surveillance mode, microglia generate low levels of ROS for:

• Signaling molecule production
• Immune surveillance
• Metabolic regulation
• Synaptic remodeling

• Rapid ROS production (100-1000x baseline)
• Phagolysosome maturation
• Pro-inflammatory cytokine release
• Antigen presentation

NOX2 Complex Assembly

The NADPH oxidase complex requires precise spatial and temporal coordination [12][13]:

| Component | Activation Trigger | Translocation |
|-----------|-------------------|---------------|
| gp91^phox^/p22^phox^ | Pre-formed | Membrane (always) |
| p47^phox^ | Phosphorylation | Cytosol → Membrane |
| p67^phox^ | Phosphorylation | Cytosol → Membrane |
| p40^phox^ | Unknown signals | Endosome → Membrane |
| Rac GTPase | GDI dissociation | Cytosol → Membrane |

p40phox in Microglia

The specific role of p40^phox^ in microglial NADPH oxidase includes:

Role in Alzheimer's Disease Pathogenesis

Amyloid-Beta-Mediated Activation

Multiple studies have demonstrated that amyloid-beta (Aβ) peptides directly activate microglial NADPH oxidase [6][14][15]:

Direct Activation:

• Aβ binds to microglial receptors (TLRs, RAGE)
• Initiates intracellular signaling cascades
• Leads to p47^phox^ phosphorylation
• Promotes NOX complex assembly

• Aβ-induced ROS increases Aβ aggregation
• More Aβ leads to more microglial activation
• Creates feed-forward neurotoxic cycle

Tau Pathology Connection

NADPH oxidase activation also connects to tau pathology [15]:

• ROS can directly modify tau proteins
• Promotes tau phosphorylation
• Facilitates tau aggregation
• Accelerates NFT formation

Therapeutic Implications

Targeting NADPH oxidase in AD has shown promise [9][16][17]:

Benefits of NOX Inhibition:

• Reduced oxidative stress
• Decreased neuroinflammation
• Improved cognitive function in animal models
• Potential disease modification

• Maintaining physiological ROS functions
• CNS penetration of inhibitors
• Timing of intervention
• Specificity for disease-related activation

Role in Parkinson's Disease Pathogenesis

SNpc Vulnerability

The substantia nigra pars compacta (SNpc) has unique vulnerabilities to NADPH oxidase-mediated damage [1]:

Microglial Density: High microglial density in SNpc Environmental Exposure: Direct exposure to blood-borne immune cells Metabolic Stress: High metabolic demand increases baseline oxidative stress

Genetic Evidence

The GWAS association of NCF4 with PD provides direct evidence [1]:

• NCF4 rs1883126 associated with increased PD risk
• Effect size: OR ~1.15 per risk allele
• Mechanistic plausibility through enhanced microglial ROS

NADPH oxidase interacts with alpha-synuclein pathology:

• α-synuclein aggregates activate microglia
• Activated microglia produce ROS
• ROS promotes further α-synuclein aggregation
• Creates vicious cycle of neurodegeneration

Signaling Pathways and Regulation

Upstream Activation Signals

p40^phox^ activation is regulated by multiple inputs:

| Signal | Mechanism | Effect |
|--------|-----------|--------|
| TLR ligands | MyD88-dependent | Potent activation |
| Cytokines (IFN-γ, TNF-α) | JAK/STAT | Enhanced expression |
| ATP/P2X7 receptors | Calcium influx | Assembly promotion |
| α-synuclein aggregates | Pattern recognition | Chronic activation |
| Aβ peptides | Multiple receptors | Sustained activation |

Negative Regulation

Several mechanisms constrain NADPH oxidase:

• SOCS proteins: Suppress cytokine signaling
• Antioxidants: Scavenge ROS (glutathione, SOD)
• PI3K signaling: Promotes p40^phox^ degradation
• Anti-inflammatory cytokines: IL-10, TGF-β

NOX2 in Neuroinflammation

The complete NOX2 complex (gp91^phox^ = CYBB) is the catalytic core [10]:

• CYBB deficiency in mice reduces neuroinflammation
• NOX2 deletion protects dopaminergic neurons
• NOX2 deficiency improves motor function in PD models

Chronic Granulomatous Disease (CGD)

NCF4 Mutations

NCF4 is one of several genes causing CGD [11]:

| Gene | Protein | Inheritance | Phenotype |
|------|---------|-------------|-----------|
| CYBB | gp91^phox^ | X-linked | Severe |
| CYBA | p22^phox^ | Autosomal | Moderate |
| NCF1 | p47^phox^ | Autosomal | Moderate |
| NCF2 | p67^phox^ | Autosomal | Moderate |
| NCF4 | p40^phox^ | Autosomal | Mild |

NCF4-Specific Features

NCF4-related CGD has distinct features:

• Milder phenotype: Residual oxidase activity
• Late onset: Often presents in adolescence
• Atypical infections: More fungal infections
• Inflammatory complications: Granuloma formation

Treatment Considerations

• Antimicrobial prophylaxis
• Interferon-gamma therapy
• Gene therapy potential
• Stem cell transplantation

Research Methods and Tools

Biochemical Approaches

• Lucigenin/cytochrome c assay: Measure superoxide production
• DHE fluorescence: ROS detection in cells
• Immunoprecipitation: Complex assembly studies
• Western blotting: Protein expression and phosphorylation

Cellular Models

• BV-2 microglia: Immortalized mouse microglia
• Primary microglia: From rodent brain
• iPSC-derived microglia: Human models
• Co-culture systems: Neuron-microglia cultures

Animal Models

• NCF4 knockout mice: For loss-of-function studies
• Transgenic models: Conditional NOX expression
• PD models: MPTP, 6-OHDA
• AD models: APP/PS1, 3xTg

Therapeutic Targeting Strategies

NOX1/NOX4 Selective Inhibitors

| Compound | Target | Stage |
|----------|--------|-------|
| GKT137831 | NOX1/NOX4 | Phase 2 trials |
| Setanaxib | NOX1/NOX4 | Clinical trials |
| ML171 | NOX1 selective | Preclinical |
| GSK2795039 | NOX2 | Preclinical |

Repositioned Drugs

Several existing drugs have NOX-inhibitory properties:

• Fingolimod: Modulates NOX activity
• Statins: Pleiotropic anti-ROS effects
• Minocycline: Anti-inflammatory beyond antibiotic

Combination Approaches

• NOX inhibition + anti-inflammatory
• NOX inhibition + antioxidant
• NOX inhibition + neuroprotective

Evolutionary Perspective

Gene Family Evolution

NCF4 and other phox genes evolved from ancestral NADPH oxidases [4]:

• Ancient NOX predates metazoan divergence
• Duplication created multiple isoforms
• NCF4 emerged specifically in vertebrates
• Adaptive evolution in immune genes

Comparative Studies

Model organisms reveal conserved functions:

• Zebrafish: NCF4 in embryonic immunity
• Drosophila: Homologs in phagocytosis
• C. elegans: NOX in host defense

Biomarker Potential

NCF4 Expression as Marker

NCF4 expression may serve as biomarker:

• Increased in neurodegenerative disease brains
• Correlates with disease severity
• Potential for disease monitoring

Therapeutic Response Marker

NOX activity could monitor treatment response:

• Reduced NCF4 expression with therapy
• Decreased ROS production
• Improved outcomes

Role in Neurodegenerative Diseases

Parkinson's Disease

Genetic association studies have identified NCF4 variants as risk factors for Parkinson's disease [1]. The mechanism involves:

The study by Gao et al. (2018) demonstrated that NCF4 polymorphisms contribute to PD risk, highlighting the importance of microglial NADPH oxidase in disease pathogenesis [1].

Alzheimer's Disease

Multiple studies have documented NADPH oxidase activation in Alzheimer's disease brains [6][7][8]:

• Amyloid-Beta Activation: Aβ peptides stimulate microglial NADPH oxidase
• Oxidative Stress: Increased ROS production in AD brain tissue
• Neuroinflammation: Amplified inflammatory responses through ROS signaling
• Neuronal Damage: ROS contribute to synaptic dysfunction and neuronal loss

NOX2 in AD and PD

Recent research by Dustin et al. (2024) provides comprehensive evidence for NOX2 (the catalytic subunit of NADPH oxidase) involvement in both Alzheimer's and Parkinson's diseases [10]. Key findings include:

• Elevated NOX2 expression in disease brains
• Correlation with disease severity
• Therapeutic potential of NOX inhibitors

Chronic Granulomatous Disease

Genetic Basis

NCF4 mutations cause a rare form of Chronic Granulomatous Disease (CGD), characterized by defective NADPH oxidase function [11]. Unlike other CGD-causing genes (CYBB, CYBA, NCF1, NCF2), NCF4 deficiency presents with a milder phenotype due to residual oxidase activity.

Clinical Features

• Recurrent infections with catalase-positive bacteria
• Impaired wound healing
• Granuloma formation
• Inflammatory complications

Expression Pattern

Immune Cell Expression

• Neutrophils: Highest expression, primary cell type
• Monocytes/Macrophages: Significant expression
• Dendritic Cells: Moderate expression

Brain Expression

• Microglia: Primary source in the CNS
• Expression is Dynamic: Increases in response to neuroinflammatory stimuli

Therapeutic Targeting

NADPH Oxidase Inhibitors

Several strategies are being explored to target the NADPH oxidase complex:

| Agent | Mechanism | Development Stage |
|-------|-----------|-------------------|
| GKT137831 | Selective NOX1/NOX4 inhibitor | Clinical trials |
| Apocynin | Prevents assembly | Preclinical |
| DPI | Flavoprotein inhibitor | Research tool |

Therapeutic Considerations

• Selective Inhibition: Targeting specific NOX isoforms to preserve host defense
• BBB Penetration: Ensuring CNS delivery for neuroprotection
• Combination Therapy: Synergy with anti-inflammatory agents

See Also

• [NCF2](/genes/ncf2) - p67^phox^ component
• [NCF1](/genes/ncf1) - p47^phox^ component
• [CYBB](/genes/cybb) - gp91^phox^ subunit (NOX2)
• [CYBA](/genes/cyba) - p22^phox^ subunit
• [NADPH Oxidase Complex](/proteins/nadph-oxidase)
• [Microglial Neuroinflammation](/cell-types/microglia-neuroinflammation)
• [Oxidative Stress Mechanism](/mechanisms/oxidative-stress)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)

External Links

• [NCBI Gene: NCF4](https://www.ncbi.nlm.nih.gov/gene/3074)
• [UniProt: Q9UHI5](https://www.uniprot.org/uniprot/Q9UHI5)
• [OMIM: 604467](https://www.omim.org/entry/604467)
• [Ensembl: ENSG00000100129](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100129)

References